Risk of acute cerebrovascular events related to low oestrogen oral contraceptive treatment

Italian Journal of Neurological Sciences

Volumn 19, Issue 1, 1998, Pages 15-19

  Scoditti, U ^a   Buccino, G P ^a   Fini, M ^a   Pattacini, C ^a   Manda, D ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Cerebral venous thrombosis; Ischemic stroke; Oral contraceptives; Retinal vein artery thrombosis

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BRAIN VEIN; CLINICAL ARTICLE; FEMALE; HUMAN; ITALY; OCCLUSIVE CEREBROVASCULAR DISEASE; ORAL DRUG ADMINISTRATION; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; TRANSIENT ISCHEMIC ATTACK; VEIN THROMBOSIS;

EID: 0031798697     PISSN: 03920461     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03028806     Document Type: Article

References (18)

1. Spitzer WO, Lewis MA, Heinemann LAJ, Thorogood M, MacRae KD (1996) Third generation oral contraceptives and risk of venous thromboembolic disorders: An international case-control study. BMJ 312:83-88
2. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1995) Venous thromboembolic disease and combined oral contraceptives: Results of an international multicentre case-control study. Lancet 346:1575-1582
3. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1995) Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 346:1582-1588
4. Hannaford PC, Croft PR, Kay CR (1994) Oral contraception and stroke. Evidence from the Royal College of General Practitioners' Oral Contraception Study. Stroke 25:935-942
5. Lidegaard O (1993) Oral contraception and risk of the cerebral thromboembolic attack: Results of a case-control study. BMJ 306:956-963
6. Petitti DB, Sidney S, Bernstein A, Wolf S, Quesenberry C, Ziel HK (1996) Stroke in users of low-dose oral contraceptives. N EnglJMed 335:8-15
7. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception (1996) Ischaemic stroke and combined oral contraceptives: Results of an international, multicentre, case-control study. Lancet 348:498-505
8. Ameri A, Bousser MG (1992) Cerebral venous thrombosis. In: Barret HJM. Machinski UC (eds) Cerebral ischemia: Treatment and prevention. Neurol Clin 10:87-111
9. Einhäupl K, Masuhr F (1994) Cerebral venous and sinus thrombosis. An update. Eur J Neurol 1:109-126
10. Cantù C, Barinagarrementeria F (1993) Cerebral venous thrombosis associated with pregnancy and puerperium. Stroke 24:1880-1884
11. Martinelli I, Landi G, Merati G, Cella R, Tosetto A. Mannucci PM (1996) Factor V gene mutation is a risk factor for cerebral venous thrombosis. Throm Haemost 75:393-394
12. Svensson PJ, Dahlbäck B (1994) Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517-522
13. Bertina RM, Koeleman BPC, Koster T et al ( 1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67
14. Bridey F. Wolff M, Laissy JP, Morin V. Lefebvre M, de Prost D (1995) Fatal cerebral venous sinus thrombosis associated with the factor V Leiden mutation and the use of oral contraceptives (letter). Thromb Haemost 74:1382
15. Rothman KJ (1986) Modern epidemiology. Little Brown, Boston
16. Bloemenkamp KWM. Rosendaal FR, Helmerhost FM. Biiller HR. Vandenbroucke JP (1995) Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third generation progestagen. Lancet 346:1593-1596
17. Koelman JHTM. Bakker CM. Plandsoen WCG. Peelers FLM. Barth PC (1992) Hereditary protein S deficiency presenting with cerebral sinus thrombosis in an adolescent girl. J Neurol 239:105-106
18. Craig SK (1994) Thrombophilia and thrombosis in unusual sites. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (eds) Haemostasis and thrombosis. Basic principles and clinical practice. 3rd ed. JB Lippincott, Philadelphia, pp 1255-1273